Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 25, Issue 7, 2012, Pages 664-670

  Wang, M T ^a,b   Chen, G ^a   An, S J ^a   Chen, Z H ^a   Huang, Z M ^a   Xiao, P ^a   Ben, X S ^a   Xie, Z ^a   Chen, S L ^a   Luo, D L ^a   Tang, J M ^a   Lin, J Y ^a   Zhang, X C ^a   Wu, Y L ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

CyclinD1; Esophageal squamous cell carcinoma; PpRb; PRb

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CANCER THERAPY; ESOPHAGUS CARCINOMA; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84866294247     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01291.x     Document Type: Article

References (25)

1. Takeuchi H, Ozawa S, Ando N etal. Altered p16/MST1/CDKN2 and cyclinD1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 1997; 12: 2229-36.
2. Bizari L, Borim A A, Leite K R M etal. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers. Cancer Genet Cytogenet 2006; 165: 41-50.
3. Huang Y, Meltzer S J, Yin J etal. Altered messenger RNA, and unique mutational profiles of p53, and Rb in human esophageal carcinomas. Cancer Res 1993; 53: 1889-94.
4. Xing E P, Yang G Y, Wang L D, Shi S T, Yang C S. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Clin Cancer Res 1999; 5: 1231-40.
5. Fukuchi M, Fukai Y, Kimura H etal. Proly1 isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol 2006; 29: 329-34.
6. Lin D C, Du X L, Wang M R. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus 2009; 22: 9-20.
7. Ralhan R, Mathew R, Arora S, Rimple B, Nootan K S, Meera M. Frequent alteration in the expression of tumour suppressor genes P16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population. J Cancer Res Clin Oncol 2000; 126: 655-60.
8. Beau-Faller M, Ruppert A M, Voegeli A C etal. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort. J Thorac Oncol 2008; 3: 331-9.
9. Yamada A, Fujii S, Daiko H, Nishimura M, Chiba T, Ochiai A. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus. Int J Oncol 2011; 38: 345-53.
10. Gospodarowicz M K, Miller D, Groome P A, Greene F L, Logan P A, Sobin L H. The process for continuous improvement of the TNM classification. Cancer 2004; 100: 1-5.
11. Lagarde S M, ten Kate F J, Reitsma J B, Busch O R, van Lanschot J J. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006; 26: 4347-55.
12. Lagarde S M, ten Kate F J, de Boer D J, Busch O R, Obertop H, van Lanschot J J. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol 2006; 30: 171-6.
13. Lerut T, Coosemans W, Decker G etal. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 2003; 126: 1121-8.
14. Eloubeidi M A, Desmond R, Arguedas M R, Reed C E, Wilcox C M. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-43.
15. Dickson G H, Singh K K, Escofet X, Kelley K. Validation of a modified GTNM classification in peri-junctional oesophagogastric carcinoma and its use as a prognostic indicator. Eur J Surg Oncol 2001; 27: 641-4.
16. Wind J, Lagarde S M, Ten Kate F J, Ubbink D T, Bemelman W A, van Lanschot J J. A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies. Eur J Surg Oncol 2007; 33: 401-8.
17. Dexter S P, Sue-Ling H, McMahon M J, Quirke P, Mapstone N, Martin I G. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001; 48: 667-70.
18. Barbour A P, Rizk N P, Gonen M etal. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007; 246: 1-8.
19. Bollschweiler E, Baldus S E, Schröder W, Schneider P M, Hölscher A H. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes: are these independent prognostic factors? J Surg Oncol 2006; 94: 355-63.
20. Wang B Y, Goan Y G, Hsu P K, Hsu W H, Wu Y C. Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg 2011; 91: 887-93.
21. Kim T, Grobmyer S R, Smith R etal. Esophageal cancer - the five year survivors. J Surg Oncol 2011; 103: 179-83.
22. Tachibana M, Kinugasa S, Yoshimura H etal. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005; 189: 98-109.
23. Conroy T, Etienne P L, Adenis A etal. Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the esophagus: response, toxicity, quality of life and survival. Ann Oncol 2002; 13: 721-9.
24. Teruhiko F, Seiya K, Hideaki Y etal. Expression of G1 cell cycle makers and the effect of adenovirus-mediated overexpression of p21Wa-1 in squamous cell carcinoma of the esophagus. Int J Oncol 2001; 18: 157-63.
25. Ikeguchi M, Sakatani T, Ueta T, Nobuaki K. CyclinD1 expression and retinoblastoma gene(pRB)expression in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2001; 127: 531-6.